Exp Clin Endocrinol Diabetes 2009; 117(9): 473-479
DOI: 10.1055/s-0029-1220769
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Ghrelin Treatment Increases Receptor-bound Leptin in Healthy and Endotoxemic Obese Lewis Rats

C. Macke1 , N. K. Prenzler1 , R. Horn2 , G. Brabant3 , H. Nave1
  • 1Institute for Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany
  • 2Clinic for Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
  • 3Department of Endocrinology, Christie's Hospital, Manchester, U.K.
Weitere Informationen

Publikationsverlauf

received 05.01.2009 first decision 11.03.2009

accepted 20.04.2009

Publikationsdatum:
29. Oktober 2009 (online)

Preview

Abstract

Obese patients with sepsis have higher morbidity and mortality rates than normal weight subjects. One crucial factor is the disease-associated disturbed energy balance. Ghrelin is an orexigenic peptide, mainly produced in the stomach. Leptin is an adipose-tissue derived peptide, circulating as free (fl) and receptor-bound protein (bl) acting antagonistically to ghrelin's effects on food intake. In the present study we tested the weight dependent influence of an intravenous (i.v.) ghrelin injection on leptin levels as well as hepatic protein expression in healthy and endotoxemic rats. Male Lewis rats were randomly divided into four diet-induced obese and four normal weight groups. Application of either ghrelin or NaCl was followed by a bolus injection of LPS or NaCl. Blood was collected at five time points (up to 24 h) to measure fl and bl by radioimmunoassay. Furthermore, hepatic leptin, leptin receptor and ghrelin expression were investigated immunohistochemically. Results revealed a late shift from high elevated fl to significantly enhanced levels of bl in ghrelin treated obese animals. Both fl and bl levels remained unaffected in lean rats. The findings suggest that an increased body weight of the treated animals is associated with altered hormone levels after therapeutic interventions with ghrelin.

References

Correspondence

Prof. Dr. H. Nave

Institute for Functional and Applied Anatomy

Hannover Medical School

Carl-Neuberg-Straße 1

30625 Hannover

Germany

Telefon: +49/511/532 36 90

Fax: +49/511/29 48

eMail: nave.heike@mh-hannover.de